?Community Outreach and Engagement The SJCCC is committed to the community we serve and addressing its clinical and research needs through education, thoughtful scientific research, community engagement and advocacy, and facilitation of access to care. Our efforts in the community are led by Dr. Carlos Rodriguez-Galindo, the SJCCC Associate Director for Outreach. The SJCCC catchment area is defined as the geographic area around Memphis and each of our 8 affiliate sites in census-tract radii. Based on the 2010 United States census data, this area represents 6,633,683 persons aged 0?19 years, with an ethnic and racial distribution of 69% White, 21% Non-Hispanic Black/African American, and 8% Hispanic. The diverse population in our catchment area includes a large proportion of low- income groups with limited resources who are medically underserved. St. Jude's 56-year-old founding policy, to which we continue to rigorously adhere, is that no patient be denied treatment based on race, ethnicity, religion, or a family's inability to pay. The SJCCC is committed to addressing treatment disparities by making resources readily available to offset not only the cost of treatment but also that of transportation and housing during clinic visits and treatment. As the only NCI-designated Cancer Center focused exclusively on children, our outreach area is further expanded beyond our local community; we also serve as a national and international referral center for pediatric cancer. There is no known variation in childhood cancer incidence and outcomes by geographic region in the United States, and relatively few discrepancies have been identified that disproportionately affect racial and ethnic minorities. Thus, our SJCCC outreach efforts continue to investigate disparities, provide cancer education for children and their parents, advocate at the state and federal level, promote the implementation of health polices relevant to our population (e.g., HPV vaccination), address the needs of an ever-growing population of childhood cancer survivors, and conduct innovative research in these areas. We will also enhance provision of implementation tools locally through our Affiliates, nationally through St. Jude?led collaborative multisite studies, and globally through capacity building and advancement of knowledge to improve the level and quality of pediatric oncology care around the world.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA021765-40
Application #
9632018
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Fuentes-Alabi, Soad; Bhakta, Nickhill; Vasquez, Roberto Franklin et al. (2018) The cost and cost-effectiveness of childhood cancer treatment in El Salvador, Central America: A report from the Childhood Cancer 2030 Network. Cancer 124:391-397
Wang, Xusheng; Jones, Drew R; Shaw, Timothy I et al. (2018) Target-Decoy-Based False Discovery Rate Estimation for Large-Scale Metabolite Identification. J Proteome Res 17:2328-2334
Sabin, N D; Cheung, Y T; Reddick, W E et al. (2018) The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only. AJNR Am J Neuroradiol 39:1919-1925
Brinkman, Tara M; Recklitis, Christopher J; Michel, Gisela et al. (2018) Psychological Symptoms, Social Outcomes, Socioeconomic Attainment, and Health Behaviors Among Survivors of Childhood Cancer: Current State of the Literature. J Clin Oncol 36:2190-2197
Follis, Ariele Viacava; Llambi, Fabien; Kalkavan, Halime et al. (2018) Regulation of apoptosis by an intrinsically disordered region of Bcl-xL. Nat Chem Biol 14:458-465
Bouchard, Jill J; Otero, Joel H; Scott, Daniel C et al. (2018) Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments. Mol Cell 72:19-36.e8
Flerlage, Jamie E; Metzger, Monika L; Bhakta, Nickhill (2018) The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice? Blood 132:376-384
Hijano, Diego R; Siefker, David T; Shrestha, Bishwas et al. (2018) Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy. Sci Rep 8:11034
Snaman, J M; Talleur, A C; Lu, J et al. (2018) Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life. Bone Marrow Transplant 53:84-90
Zheng, Daniel J; Krull, Kevin R; Chen, Yan et al. (2018) Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. Cancer 124:3220-3230

Showing the most recent 10 out of 6764 publications